Sunshine Biopharma Inc (SBFM)

[DDMasterStocks]

SBFM RETIRES 78M shares! O/S is 200M after SHARE BUY BACK last week!

That is a 28% reduction in the Outstanding Shares as of 8/19/2020.


DTC registered shares puts the actual available shares at 185M.

From the 10-Q posted 8/19/2020

The number of shares of the registrant’s only class of Common Stock issued and outstanding as of August 18, 2020, was 200,308,644 shares.

https://sec.report/Document/0001654954-20-009340/

https://sec.report/Ticker/SBFM


SBFM is a Covid-19 & FDA play with two priority and fast track submissions with the FDA and US Patent office for their covid-19 vaccine and treatment!

On May 22, 2020, SBFM filed for FDA approval and US Patent.

Sunshine Biopharma Files A Patent Application For A New Coronavirus COVID-19 Treatment

https://finance.yahoo.com/news/sunshine-biopharma-files-patent-application-130000935.html

SBFM is also in the process or distributing generic products by Astrazeneca!

The following drugs will or are available by SBFM:

Anastrozole (brand name Arimidex® by AstraZeneca) for treatment of Breast Cancer
Letrozole (brand name Femara® by Novartis) for treatment of Breast Cancer
Bicalutamide (brand name Casodex® by AstraZeneca) for treatment of Prostate Cancer
Finasteride (brand name Propecia® by Merck) for treatment of BPH (Benign Prostatic Hyperplasia)

See previous 10-Q, mentioning the generics:

https://sec.report/Document/0001654954-20-005714/
and SBFM's press release

https://sunshinebiopharma.com/press-releases.html
https://sunshinebiopharma.com/drugs-market.html